Literature DB >> 19767593

Short-term effectiveness of medication and psychosocial intervention in a cohort of newly diagnosed patients with inattention, impulsivity, and hyperactivity problems.

Bruno Falissard1, David Coghill, Aribert Rothenberger, Maria Lorenzo.   

Abstract

OBJECTIVE: The article discusses the ADHD Observational Research in Europe (ADORE) study that examined the impact of early treatment choices on outcome within the first few months, in previously untreated children with impairing inattention, impulsivity, and hyperactivity.
METHODS: Data are collected from a longitudinal, observational study conducted in 10 European countries that involve 1,478 children (aged 6 to 18 years) with symptoms of hyperactivity, impulsivity, or inattentiveness. Linear model with a propensity score adjustment compares the decrease in ADHD-RS scores between baseline and last recorded visit across treatment groups (2 to 5 months).
RESULTS: At baseline, 49.9% of participants are prescribed pharmacotherapy and 44.3% a psychosocial intervention. Analysis of the effect of treatment on the evolution of ADHD-RS scores shows a positive effect of medications and either an insignificant or negative effect of psychosocial intervention.
CONCLUSIONS: Early use of medication effectively reduces ADHD symptoms in routine clinical practice in Europe. The effect of psychosocial intervention has to be interpreted cautiously because the number, length, and level of standard of the sessions are not taken into account in the analyses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767593     DOI: 10.1177/1087054709347173

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  6 in total

1.  Clinical factors associated with decision to recommend methylphenidate treatment for children with ADHD in France.

Authors:  Elodie Courtabessis; Florence Pupier; Laurie Surig; Marie-Christine Picot; Erika Nogué; Valérie Macioce; Elizabeth Stein; Diane Purper-Ouakil
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-10-05       Impact factor: 4.785

2.  Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia.

Authors:  Jihyung Hong; Diego Novick; Tamás Treuer; William Montgomery; Virginia S Haynes; Shenghu Wu; Josep Maria Haro
Journal:  BMC Psychiatry       Date:  2014-10-30       Impact factor: 3.630

3.  Attention-deficit/hyperactivity disorder Under Treatment Outcomes Research (AUTOR): a European observational study in pediatric subjects.

Authors:  Virginia Haynes; Pedro Lopez-Romero; Ernie Anand
Journal:  Atten Defic Hyperact Disord       Date:  2015-06-27

4.  Barriers and predictors of medication use for childhood ADHD: findings from a UK population-representative cohort.

Authors:  A E Russell; T Ford; G Russell
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-05-09       Impact factor: 4.328

5.  Third-generation cognitive behavioral therapy versus treatment-as-usual for attention deficit and hyperactivity disorder: a multicenter randomized controlled trial.

Authors:  Laetitia Crouzet; Anne Gramond; Carey Suehs; Pascale Fabbro-Peray; Mocrane Abbar; Jorge Lopez-Castroman
Journal:  Trials       Date:  2022-01-28       Impact factor: 2.279

6.  Child and Parental Characteristics of Medication Use for Attention-Deficit/Hyperactivity Disorder.

Authors:  Beate Oerbeck; Kari Furu; Pal Zeiner; Heidi Aase; Ted Reichborn-Kjennerud; Are Hugo Pripp; Kristin Romvig Overgaard
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-07-14       Impact factor: 2.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.